Literature DB >> 36102969

Combinatorial treatment with β-glucanase enzyme and chlorhexidine induces cysticidal effects in Acanthamoeba cyst.

Nurhidayana Mohd Rased1, Syed Ahmad Tajudin Tuan Johari2, Hazlina Ahamad Zakeri3, Nyuk Ling Ma3, Siti Aisyah Razali4, Fatimah Hashim5.   

Abstract

Acanthamoeba cysts have a cellulose cell wall made up of a solid layer of β-glucan, which confers resistance to the dormant phase of this microorganism. The ability of Acanthamoeba to change to this dormant phase causes difficulties in treating its infection at the cyst stage as compared to the trophozoite stage. Therefore, targeting cyst total mortality can help to prevent re-infection in patients. To ensure cysticidal treatment, a β-glucanase enzyme was introduced in vitro to the Acanthamoeba cyst, followed by a chlorhexidine solution treatment. β-glucanase enzyme and chlorhexidine dose-response analysis was performed based on cell wall integrity measurement. The treatment was also performed on human corneal epithelial cells to confirm the safety of the treatment in vitro. The surface morphology of the cysts was observed using scanning electron microscopy (SEM), while the protein alterations were determined using 1D protein analysis. The interaction of the β-glucanase enzyme with cellulose linkages was investigated based on molecular dosimetry. Incubation of the cyst for 24 h at 8.75 units/ml of β-glucanase followed by 0.88 μg/ml of chlorhexidine resulted in a substantial reduction in the total chlorhexidine used, which made it safer for human corneal epithelial cells. Ultrastructural changes revealed the reduction of the thickness in ectocyst and endocyst layers with the loss of the internal structure of the cyst. After combination treatment of chlorhexidine and β-glucanase, a decrease in the cyst protein from the size of 37 to 25 kDa was observed. The enzyme-substrate interaction validated these results based on molecular docking between 1,4-β-D-glucan and 1,4- β-D-xylan with the β-glucanase enzyme. In silico analysis revealed that two catalytic glutamate residues (Glu160 and Glu267) are essential to catalysing the hydrolytic reaction. Molecular dynamic simulation analysis revealed that both ligands formed stable interactions throughout the simulation. This work concludes that the enzymatic approach combined with chlorhexidine is a novel and effective technique for ensuring the cysticidal effects against the Acanthamoeba cyst. The interaction of the chlorhexidine and β-glucanase enzyme on the surface of the cyst of amoeba resulted in the ecto-and endo cyst layer being damaged and confirmed the cysticidal effects.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Cell wall; Cellulose; Chlorhexidine; Human corneal epithelial cell; Protein

Mesh:

Substances:

Year:  2022        PMID: 36102969     DOI: 10.1007/s00436-022-07650-0

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.383


  16 in total

1.  Characterization of a broad-specificity β-glucanase acting on β-(1,3)-, β-(1,4)-, and β-(1,6)-glucans that defines a new glycoside hydrolase family.

Authors:  Mickael Lafond; David Navarro; Mireille Haon; Marie Couturier; Jean-Guy Berrin
Journal:  Appl Environ Microbiol       Date:  2012-09-28       Impact factor: 4.792

2.  In vitro anti-Acanthamoeba synergistic effect of chlorhexidine and cationic carbosilane dendrimers against both trophozoite and cyst forms.

Authors:  I Heredero-Bermejo; J Sánchez-Nieves; J Soliveri; R Gómez; F J de la Mata; J L Copa-Patiño; J Pérez-Serrano
Journal:  Int J Pharm       Date:  2016-05-10       Impact factor: 5.875

3.  Comparison of polyhexamethylene biguanide and chlorhexidine as monotherapy agents in the treatment of Acanthamoeba keratitis.

Authors:  Natasha Lim; David Goh; Catey Bunce; Wen Xing; Graham Fraenkel; Tom R G Poole; Linda Ficker
Journal:  Am J Ophthalmol       Date:  2007-11-08       Impact factor: 5.258

4.  Component Analysis of Multipurpose Contact Lens Solutions To Enhance Activity against Pseudomonas aeruginosa and Staphylococcus aureus.

Authors:  Leo Lin; Janie Kim; Hope Chen; Regis Kowalski; Victor Nizet
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

5.  Carbohydrate analysis of Acanthamoeba castellanii.

Authors:  Ricky Dudley; Edward L Jarroll; Naveed Ahmed Khan
Journal:  Exp Parasitol       Date:  2009-04-21       Impact factor: 2.011

6.  Cysticidal effect on acanthamoeba and toxicity on human keratocytes by polyhexamethylene biguanide and chlorhexidine.

Authors:  Ji-Eun Lee; Boo Sup Oum; Hee Young Choi; Hak Sun Yu; Jong Soo Lee
Journal:  Cornea       Date:  2007-07       Impact factor: 2.651

7.  Computational protein-ligand docking and virtual drug screening with the AutoDock suite.

Authors:  Stefano Forli; Ruth Huey; Michael E Pique; Michel F Sanner; David S Goodsell; Arthur J Olson
Journal:  Nat Protoc       Date:  2016-04-14       Impact factor: 13.491

Review 8.  An update on Acanthamoeba keratitis: diagnosis, pathogenesis and treatment.

Authors:  Jacob Lorenzo-Morales; Naveed A Khan; Julia Walochnik
Journal:  Parasite       Date:  2015-02-18       Impact factor: 3.000

9.  The most abundant cyst wall proteins of Acanthamoeba castellanii are lectins that bind cellulose and localize to distinct structures in developing and mature cyst walls.

Authors:  Pamela Magistrado-Coxen; Yousuf Aqeel; Angelo Lopez; John R Haserick; Breeanna R Urbanowicz; Catherine E Costello; John Samuelson
Journal:  PLoS Negl Trop Dis       Date:  2019-05-16

10.  Curcuma longa rhizome extract and Curcumin reduce the adhesion of Acanthamoeba triangularis trophozoites and cysts in polystyrene plastic surface and contact lens.

Authors:  Watcharapong Mitsuwan; Suthinee Sangkanu; Chonticha Romyasamit; Chalermpon Kaewjai; Tajudeen O Jimoh; Maria de Lourdes Pereira; Abolghasem Siyadatpanah; Sunil Kayesth; Muhammad Nawaz; Mohammed Rahmatullah; Mark S Butler; Polrat Wilairatana; Christophe Wiart; Veeranoot Nissapatorn
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2020-11-17       Impact factor: 4.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.